CSL Executive and Leadership Team

Ken Lim, the Chief Financial Officer at CSL, directs the global financial strategy and capital allocation for the biotechnology portfolio. Overseeing fiscal planning, the Chief Financial Officer ensures the company maintains robust liquidity to support the development of lifesaving medicines for hemophilia and immune deficiencies. This leadership role involves managing investor relations and coordinating with the Board to optimize long-term shareholder value. By implementing rigorous cost-control measures across international operations, Ken Lim strengthens the financial foundation necessary for sustained research investment. The Chief Financial Officer monitors market trends in iron deficiency and nephrology to guide resource distribution. Through precise financial oversight, Lim secures the capital required to advance the mission of saving lives using the latest technologies.

Jody Long, the Administrative Advisor To Chief Financial Officer at CSL, coordinates the operational workflows and strategic initiatives within the finance department. Overseeing the administrative infrastructure, the Administrative Advisor To Chief Financial Officer facilitates communication between executive leadership and internal stakeholders to ensure alignment with corporate financial goals. This role involves streamlining reporting processes for the global portfolio of lifesaving medicines. By managing complex project timelines, Jody Long supports the Chief Financial Officer in executing high-level fiscal policies. The Administrative Advisor To Chief Financial Officer monitors departmental performance metrics to identify opportunities for increased efficiency. Through meticulous organizational oversight, Long enables the finance team to focus on the core mission of delivering therapies for immune deficiencies and other critical health conditions.

Emiliano Chiaramonte, the Chief Financial Officer, LATAM (South) at CSL, manages the financial operations and fiscal strategy for the southern region of Latin America. Overseeing regional budget allocation, the Chief Financial Officer, LATAM (South) ensures that resources are effectively directed toward the distribution of therapies for immune deficiencies and other critical conditions. This role involves navigating complex economic environments to maintain profitability and support regional growth. By analyzing local market trends, Emiliano Chiaramonte provides the financial insights necessary for strategic decision-making. The Chief Financial Officer, LATAM (South) coordinates with global finance leadership to ensure alignment with corporate objectives. Through disciplined financial management, Chiaramonte strengthens the company's market position in the region, ensuring that lifesaving medicines remain accessible to patients across the southern territories.

Eric McKay, the Regional Category Manager & Chief Marketing Officer, Research & Development at CSL, architects the commercialization strategy for emerging therapeutic pipelines. Overseeing the integration of research data into market-facing campaigns, the Chief Marketing Officer ensures that innovations in influenza prevention reach target patient populations effectively. This role requires close collaboration with the research teams to translate complex scientific advancements into accessible medical solutions. By driving regional category growth, McKay aligns product positioning with the specific needs of global healthcare providers. The Chief Marketing Officer manages the strategic rollout of new therapies, ensuring consistent messaging across diverse international markets. Eric McKay optimizes the commercial lifecycle of biotechnology assets, directly supporting the corporate objective of expanding access to critical treatments.

Amanda Taylor, the Chief Marketing Officer, Campaign & Manager (Americas) at CSL, executes the regional marketing strategy across the North and South American markets. Overseeing the development of patient-centric campaigns, the Chief Marketing Officer ensures that therapies for hemophilia and iron deficiency reach the appropriate clinical settings. This role involves managing regional brand presence and coordinating with local healthcare networks to improve patient outcomes. By analyzing market demand, Amanda Taylor optimizes the distribution of lifesaving medicines throughout the Americas. The Chief Marketing Officer collaborates with cross-functional teams to ensure that marketing initiatives reflect the latest technological advancements in biotechnology. Through targeted outreach and strategic planning, Taylor drives market penetration and strengthens the company's reputation as a leader in the regional health services sector.

Candice Nieves, the Manager Chief Marketing Officer Quality at CSL, directs the quality assurance protocols for all marketing and promotional materials. Overseeing compliance with global regulatory standards, the Manager Chief Marketing Officer Quality ensures that all communications regarding lifesaving medicines remain accurate and transparent. This role involves auditing campaign content to verify that scientific claims align with the latest clinical data for vaccines and therapies. By implementing rigorous review processes, Candice Nieves mitigates risk and maintains the integrity of the brand across international markets. The Manager Chief Marketing Officer Quality works closely with legal and medical affairs to uphold the highest standards of corporate responsibility. Through consistent quality oversight, Nieves supports the company's commitment to patient safety and ethical communication in the biotechnology industry.

Hamza Shanaa, the Manager Chief Marketing Officer Quality at CSL, architects the quality management systems for global marketing operations. Overseeing the standardization of promotional assets, the Manager Chief Marketing Officer Quality ensures that all regional teams adhere to strict corporate guidelines. This role involves monitoring the effectiveness of quality control measures in the delivery of information regarding influenza vaccines and nephrology therapies. By identifying process improvements, Hamza Shanaa enhances the efficiency of the marketing review cycle. The Manager Chief Marketing Officer Quality collaborates with global stakeholders to ensure that all messaging supports the overarching mission of saving lives. Through continuous evaluation of quality metrics, Shanaa maintains the high standards expected of a global biotechnology leader, ensuring that every communication reflects the company's dedication to scientific excellence.

Phyllis Post, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T at CSL, directs the digital transformation and information technology infrastructure across the global business units. Overseeing the integration of advanced data systems, the Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T ensures that research and manufacturing teams have the technological tools necessary to develop lifesaving medicines. This role involves managing cybersecurity protocols and cloud infrastructure to protect sensitive clinical data. By optimizing IT operations, Phyllis Post supports the seamless flow of information between global research centers and commercial hubs. The Vice President and Chief Information Officer, CSL Behring, Seqirus and Vifor I & T drives innovation in digital health, enabling the company to scale its operations effectively while maintaining the highest standards of data integrity.

Ruby Eappen, the Global Quality Manager, Supplier & Chief Marketing Officer at CSL, directs the quality standards for the global supply chain and marketing interface. Overseeing supplier compliance, the Global Quality Manager, Supplier & Chief Marketing Officer ensures that all raw materials used in the production of lifesaving medicines meet rigorous safety requirements. This role involves auditing global vendors to maintain the integrity of the manufacturing process for vaccines and therapies. By integrating quality assurance into the marketing strategy, Ruby Eappen ensures that the company's promise to save lives is reflected in every aspect of the product lifecycle. The Global Quality Manager, Supplier & Chief Marketing Officer collaborates with procurement and marketing teams to optimize supply chain reliability. Through proactive quality management, Eappen supports the company's mission of delivering high-quality biotechnology solutions worldwide.

Henry Mezzanotte, the Executive Vice President & Head Chief Medical Officer, Research Development at CSL, leads the global clinical strategy and the development of the next generation of lifesaving medicines. Overseeing the research pipeline, the Executive Vice President & Head Chief Medical Officer, Research Development ensures that scientific innovation translates into effective treatments for hemophilia, immune deficiencies, and nephrology. This role involves guiding clinical trials and collaborating with regulatory bodies to bring new therapies to market. By directing the research and development teams, Henry Mezzanotte fosters a culture of scientific excellence and patient-focused discovery. The Executive Vice President & Head Chief Medical Officer, Research Development monitors global health trends to prioritize therapeutic areas with the highest unmet needs. Through visionary leadership, Mezzanotte drives the company's commitment to using the latest technologies to save lives.